Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.jubilantingrevia.com | |
Market Cap | 5,745.27 Cr. | |
Enterprise Value(EV) | 6,027.12 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 20.33 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 17.74 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 26.16 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 168.69 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 2.14 | Calculated using Price: 360.70 |
Dividend Yield | 1.39 | Period Ending 2022-03 |
No. of Shares Subscribed | 15.93 Cr. | 159,281,139 Shares |
FaceValue | 1 | |
Company Profile | ||
The company offers a broad portfolio of high-quality ingredients that find application in a wide range of industries. The company's portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. |
1 Day |
|
+0.64% |
1 Week |
|
-9.39% |
1 Month |
|
-18.93% |
3 Month |
|
-32.05% |
6 Month |
|
-29.84% |
1 Year |
|
-22.06% |
2 Year |
|
+40.68% |
5 Year |
|
|
10 Year |
|
3 years | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 5.65 | 21.89 | ||
Return on Capital Employed (%) | 6.86 | 28.84 | ||
Return on Assets (%) | -332.00 | 3.23 | 13.34 |
Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 0 | 1,923 | 2,433 | 2,556 | |
Non Curr. Liab. | 549 | 296 | 220 | ||
Curr. Liab. | 0 | 894 | 1,053 | 1,312 | |
Minority Int. | |||||
Equity & Liab. | 0 | 3,366 | 3,782 | 4,088 | |
Non Curr. Assets | 1,943 | 2,018 | 2,173 | ||
Curr. Assets | 0 | 1,424 | 1,765 | 1,915 | |
Misc. Exp. not W/O | |||||
Total Assets | 0 | 3,366 | 3,782 | 4,088 |
Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 684 | 4,949 | 4,923 | ||
Other Income | 3 | 31 | 34 | ||
Total Income | 687 | 4,981 | 4,957 | ||
Total Expenditure | 0 | -567 | -4,118 | -4,336 | |
PBIDT | 0 | 120 | 863 | 621 | |
Interest | -7 | -31 | -22 | ||
Depreciation | -22 | -123 | -123 | ||
Taxation | -23 | -232 | -152 | ||
Exceptional Items | -13 | ||||
PAT | 0 | 54 | 477 | 324 | |
Minority Interest | |||||
Share Associate | 0 | ||||
Other Related Items | |||||
Consolidated Net Profit | 0 | 54 | 477 | 324 | |
Adjusted EPS | -3 | 3 | 30 | 20 |
Particulars | 3 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 112 | 453 | ||
Cash Fr. Inv. | -44 | -72 | ||
Cash Fr. Finan. | 0 | -72 | -418 | |
Net Change | 0 | -4 | -37 | |
Cash & Cash Eqvt | 0 | 73 | 38 |
Wed, 29 Mar 2023
Intimation of Repayment of Commercial Paper (CP) We wish to inform you that Commercial Paper of Rs. 150 Crores bearing ISIN INE0BY014128 issued on February 09 2023 has been fully redeemed by the Company on March 29 2023.Further to inform that the date of maturity of Commercial Paper is on March 30 2023 that happens to be a holiday therefore the payment is made on the immediately preceding working day i.e. March 29 2023.This is for your kind information and record. |
Wed, 29 Mar 2023
Certificate Under Chapter XVII Of SEBI Operational Circular Dated 10Th August 2021 Pursuant to Chapter XVII OF SEBI Operational Circular dated 10th August 2021 we hereby confirm that the Company has fulfilled its payment obligation in respect of redemption of Commercial Paper (CPs) of Rs. 150 Crores.The date of maturity of Commercial Paper happens to be a holiday i.e. March 30 2023. Therefore the payment is made on the immediately preceding working day i.e. March 29 2023. |
Fri, 24 Mar 2023
Closure of Trading Window Pursuant to the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company will be closed for Designated Persons from March 25 2023 and the same shall remain closed till 48 hours after announcement of Financial Results for the quarter and year ending March 31 2023 to the Stock Exchanges.Accordingly the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of Trading Window.This is for your information and records. |
Wed, 29 Mar 2023 |
|
|
|
|
|